Kamil Ali Jackson Aclaris Therapeutics, Inc. (ACRS) insider trading activity

Kamil Ali Jackson is Chief Legal Officer of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 160,214 shares of ACRS, which is worth approximately $692,124. The most recent transaction as insider was on Jan 03, 2022, when has been sold 45,518 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 160K

0% 3M change

0% 12M change

Total Value Held $692,124

Kamil Ali-Jackson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2022	BUY Exercise of conversion of derivative security	-	45,518 Added 22.12%	160,214 Common Stock
Jun 03 2021	SELL Open market or private sale	$208,444 $21.96 p/Share	9,492 Reduced 7.21%	122,196 Common Stock
Jun 02 2021	SELL Open market or private sale	$659,907 $21.91 p/Share	30,119 Reduced 18.61%	131,688 Common Stock
Jun 01 2021	SELL Open market or private sale	$347,250 $23.15 p/Share	15,000 Reduced 8.48%	161,807 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	-	33,189 Added 15.8%	176,807 Common Stock
May 07 2021	SELL Open market or private sale	$127,872 $23.61 p/Share	5,416 Reduced 3.63%	143,618 Common Stock
May 07 2021	BUY Exercise of conversion of derivative security	$57,735 $10.66 p/Share	5,416 Added 3.51%	149,034 Common Stock
May 06 2021	SELL Open market or private sale	$353,850 $23.59 p/Share	15,000 Reduced 9.46%	143,618 Common Stock
May 06 2021	BUY Exercise of conversion of derivative security	$159,900 $10.66 p/Share	15,000 Added 8.64%	158,618 Common Stock
May 05 2021	SELL Open market or private sale	$362,550 $24.17 p/Share	15,000 Reduced 9.46%	143,618 Common Stock
May 05 2021	BUY Exercise of conversion of derivative security	$159,900 $10.66 p/Share	15,000 Added 8.64%	158,618 Common Stock
May 04 2021	SELL Open market or private sale	$360,600 $24.04 p/Share	15,000 Reduced 9.46%	143,618 Common Stock
May 04 2021	BUY Exercise of conversion of derivative security	$159,900 $10.66 p/Share	15,000 Added 8.64%	158,618 Common Stock
May 03 2021	SELL Open market or private sale	$370,200 $24.68 p/Share	15,000 Reduced 9.46%	143,618 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$159,900 $10.66 p/Share	15,000 Added 8.64%	158,618 Common Stock
Mar 11 2021	SELL Bona fide gift	-	7,500 Reduced 6.14%	114,696 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$44,314 $23.25 p/Share	1,906 Reduced 1.31%	143,618 Common Stock
Mar 02 2021	BUY Exercise of conversion of derivative security	-	6,637 Added 4.36%	145,524 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$118,712 $24.06 p/Share	4,934 Reduced 3.43%	138,887 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	-	17,175 Added 10.67%	143,821 Common Stock
Feb 01 2021	SELL Payment of exercise price or tax liability	$28,139 $21.35 p/Share	1,318 Reduced 1.03%	126,646 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	-	3,875 Added 2.94%	127,964 Common Stock
Dec 15 2020	SELL Payment of exercise price or tax liability	$2,286 $4.59 p/Share	498 Reduced 0.4%	124,089 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	-	1,734 Added 1.37%	124,587 Common Stock

Also insider at

PDSB

PDS Biotechnology Corp Healthcare

RIGL

RIGEL PHARMACEUTICALS INC Healthcare